Pulnovo Medical
Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Sep 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Pulnovo Medical is the developer of the PADN system and sponsor of the trial. The positive results and NEJM publication are expected to enhance its commercial prospects and regulatory momentum.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Pulnovo Medical live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard